You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 62011-0433


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 62011-0433

Drug Name NDC Price/Unit ($) Unit Date
HM DOCOSANOL 10% CREAM 62011-0433-01 6.02264 GM 2024-12-18
HM DOCOSANOL 10% CREAM 62011-0433-01 5.97526 GM 2024-11-20
HM DOCOSANOL 10% CREAM 62011-0433-01 6.08696 GM 2024-10-23
HM DOCOSANOL 10% CREAM 62011-0433-01 6.07323 GM 2024-09-18
HM DOCOSANOL 10% CREAM 62011-0433-01 5.78000 GM 2024-08-21
HM DOCOSANOL 10% CREAM 62011-0433-01 5.79446 GM 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 62011-0433

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

62011-0433 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 62011-0433

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code[4].

Identifying the Drug

The NDC 62011-0433 can be broken down as follows:

  • Labeler Code: 62011
  • Product Code: 0433
  • Package Code: The last segment, which is not always explicitly shown, indicates the packaging configuration.

Using the FDA's National Drug Code Directory, you can find detailed information about the drug, including its name, dosage form, and strength[4].

Market Trends in the Pharmaceutical Industry

The pharmaceutical market is complex and influenced by various factors, including regulatory changes, competition, and global pricing trends.

Global Pricing Trends

In the U.S., the average price per unit of drugs is significantly higher compared to other countries. For instance, in 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world[3].

Sales Revenue Trends

U.S. sales revenues for both retail and non-retail drugs have shown substantial growth. Between 2017 and 2022, retail drug sales revenues increased by 22%, while non-retail drug sales revenues increased by 26%. In contrast, retail sales revenues decreased in other parts of the world and OECD countries, while non-retail sales revenues saw moderate growth[3].

Price Projections

Historical Price Trends

To project future prices, it is essential to analyze historical price trends. Between 2017 and 2022, the U.S. saw an average price increase of 14% for all drugs, while other regions experienced decreases in average prices[3].

Impact of Regulatory Changes

Regulatory changes can significantly impact drug prices. For example, the Open Payments system, which requires reporting of payments associated with drugs, can influence transparency and potentially affect pricing strategies. Ensuring that the drug name and NDC match the CMS-approved dataset is crucial for compliance[1].

Competition and Market Dynamics

The level of competition in the market for the specific drug identified by NDC 62011-0433 will also influence price projections. If the drug is part of a highly competitive market, prices may be more stable or even decrease due to market pressure. Conversely, if the drug has limited competition, prices could remain high or increase.

Specific Analysis for NDC 62011-0433

Current Market Position

To accurately project prices, one must understand the current market position of the drug. This includes its market share, the number of competitors, and any recent changes in demand or supply.

Pricing Strategy

Pharmaceutical companies often employ various pricing strategies, such as value-based pricing, competitive pricing, or penetration pricing. Understanding the pricing strategy adopted by the manufacturer of the drug with NDC 62011-0433 is crucial for predicting future price movements.

Data Conversion and Reporting

NDC Format

Ensuring the correct format of the NDC is important for billing and reporting purposes. The NDC must be in an 11-digit format, which may require converting from a 10-digit format found on packaging[2].

Key Takeaways

  • Global Pricing Trends: The U.S. has significantly higher drug prices compared to other regions.
  • Sales Revenue Trends: U.S. sales revenues for both retail and non-retail drugs have increased substantially.
  • Regulatory Compliance: Ensuring the drug name and NDC match the CMS-approved dataset is crucial for reporting payments.
  • Market Dynamics: Competition and market dynamics play a significant role in price projections.
  • Pricing Strategies: Understanding the pricing strategy of the manufacturer is essential for predicting future price movements.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs, including the labeler code, product code, and package code[4].
  2. How do I convert a 10-digit NDC to an 11-digit format?

    • Converting a 10-digit NDC to an 11-digit format requires strategically placing a zero, depending on the 10-digit format. A conversion table can be used to guide this process[2].
  3. Why are drug prices in the U.S. higher than in other countries?

    • Drug prices in the U.S. are influenced by higher prices and a drug mix that skews towards higher-cost drugs compared to other regions[3].
  4. What is the Open Payments system, and how does it affect drug pricing?

    • The Open Payments system requires reporting of payments associated with drugs. Ensuring compliance can influence transparency and potentially affect pricing strategies[1].
  5. How often is the FDA's National Drug Code Directory updated?

    • The FDA's National Drug Code Directory is updated daily and includes information on active and certified finished and unfinished drugs submitted by labelers[4].

Sources

  1. Drug Name and National Drug Code (NDC) Reference Data Instructions - CMS
  2. National Drug Code (NDC) Conversion Table - Maryland Department of Health
  3. International Prescription Drug Price Comparisons - ASPE
  4. National Drug Code Directory - FDA
  5. National Drug Code Directory - HealthData.gov

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.